Hematopoietic cell transplantation (HCT) information center: A data management system and a gateway to standard statistics  by Saracino, G. et al.
infection in the intermediate period and deaths caused by multire-
sistant Gram-negative bacteria in the late period were revealed.
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CORE INFORMATION REPORTED TO DONOR CENTERS AFTER ALLOGE-
NEIC STEM CELL TRANSPLANTATION (SCT)
Laursen, H.B., Lanther, T., Holder, J. Rigshospitalet, BMT Unit 4042,
Copenhagen, Denmark.
Background. The purpose of this study is to identify the follow-
ing topics: (1) what information regarding the recipient’s medical
history European Donor Centers (EDC) deﬁne as essential; (2)
frequency of recipient follow-up (FU) information to EDCs; and
(3) information ﬂow to the donor regarding the recipients medical
history posttransplantation. Methods. A questionnaire was faxed
to 38 EDCs. Of these, 21 (55.3%) responded. One of these 21
EDCs declined to answer, and another had delegated the FU
program to another national center, so the results are based on the
19 EDCs that completed the questionnaire. Results. Sixteen of the
19 EDCs (84.2%) had a recipient FU questionnaire. The following
analysis is based on the answers from the 16 EDCs with a FU
questionnaire.The frequency of FU information by days (D) post
SCT was D 30, 4 EDCs; D 60, 1 EDC; D 90, 6 EDCs; D 100, 3
EDCs; D 120, 2 EDCs; D 180, 8 EDCs; 1 year, 13 EDCs; yearly,
11 EDCs. Fourteen of the 16 (87.5%) EDCs with a FU program
used the same questionnaire for all FU requests, and 6 (37.5%) of
the 16 EDCs redesigned their FU questionnaire according to
research projects. The EDCs’ frequency of follow-up information
was based on national standards in 4 (25%), international standards
in 7 (43.8%), both national and international standards in 2
(12.5%), and other standards in 3 (18.8%).
The donor access to FU information regarding the recipients
condition was given as follows: no information given in 3 (17.8%),
information automatically given to the donor in 3 (18.8%), infor-
mation given on donor request in 8 (50%), information given by
the collection center in 1 (6.3%), and other in 1 (6.3%).
Changes in the patient’s condition are not reported to the donor
in 13 (81.2%), are reported to the donor in 1 (6.3%), and are
reported only on request from the donor in 5 (31.3%). The donor
is not informed if the patient dies in 8 (50%), the donor is informed
in 3 (18.8%), and the donor is informed only on request in 5
(31.3%).
Twelve EDCs gave information on the content of their FU
questionnaire. The most frequent questions asked are regarding
date of transplantation and survival status in 12 (100%); date and
cause of death, Lansky/Karnofsky score in 11 (91.7%); AGvHD,
recurrence or relapse of disease in 10 (83.3%); engraftment, re-
transplantation/DCI in 9 (75%); and chronic GvHD in 8 (66.7%).
Conclusions. Because only 55.3% of the EDCs participated in
this study. the results should be interpreted with caution. Most
EDCs have a recipient FU program, but there is no agreement
among EDC on dates of the FU information and by what standards
this information should be provided. Some 82% of the EDCs
provide information to the donor regarding the recipient’s condi-
tion.
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Background. Efﬁcient data collection and management of HCT
clinical data are essential in reporting patient transplantation out-
come and clinical research. Collection of this data in real time with
frequent updates requiring daily communication between data
managers, clinical investigators and afﬁliated staff is challenging,
especially in a large hematopoietic cell transplantation program.
Such an approach, however, minimizes the incidence of missing
data and facilitates a complete and accurate transplantation data-
base. Thus, transplantation data collected in this fashion should
result in high-quality data for cooperative transplantation regis-
tries, manuscript submission, and ﬁnancial staff. The aims of this
study were to provide a user-friendly interface to standardized
transplantation outcome statistics, and to provide access to various
data management applications to authorized users within the trans-
plantation program provided by a HCT Information Center at
Baylor University Medical Center (BUMC). Method. The HCT
Information Center at BUMC has been established to provide a
web-based interface for reporting, statistical analysis, and online
forms. The system includes SAS macros developed to process
data from Oracle and Microsoft Access databases and to create
customized reports, standard statistics,and SAS ActiveX graphs
updated automatically. The system provides different levels of
access to different groups of authorized users. Results. The pro-
cesses of data management, quality assurance monitoring, and data
validation have been supported by customized reports and tracking
tools (eg, last contact/follow-up, missing data, error reporting).
Physicians, clinical investigators, and authorized users have access
to valid up-to-date statistical information regarding patients/do-
nors undergoing blood and marrow transplantation. Examples of
available analysis include disease-related outcome statistics, such as
Kaplan-Mayer survival curves, and analysis of infection control
data, such as trends in antibiotic resistance patterns. Conclusions.
The HCT Information Center provides users with beneﬁcial and
accurate information that allows tracking of patients’ progress
during and after transplantation as well as long-term outcomes. It
allows us to compare our center’s outcomes with those published
by CIBMTR. Most important, it helps us ensure better quality and
completeness of the data collected for publication and submission
to transplantation reporting agencies.
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